# FMC Corp: Form 10-Q for the period ended Mar 31, 2016

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2016-05-03
- Accepted by EDGAR: May 3, 2016, 20:55 ET
- Period: 2016-03-31
- Accession: 0000037785-16-000087
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778516000087/fmc331201610q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778516000087/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-01-01 to 2016-03-31 | $798.8m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2016-01-01 to 2016-03-31 | $517.4m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2016-01-01 to 2016-03-31 | $281.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2016-01-01 to 2016-03-31 | $126.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2016-01-01 to 2016-03-31 | $106.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2016-01-01 to 2016-03-31 | $30.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-01-01 to 2016-03-31 | $48.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2016-01-01 to 2016-03-31 | $0.36 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2016-01-01 to 2016-03-31 | $0.36 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2016-01-01 to 2016-03-31 | 134,304,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2016-01-01 to 2016-03-31 | $107.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2016-01-01 to 2016-03-31 | $41.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2016-01-01 to 2016-03-31 | $22.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2016-03-31 | $64.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-03-31 | $2.96bn | us-gaap:AssetsCurrent |
| Total assets | at 2016-03-31 | $6.39bn | us-gaap:Assets |
| Current liabilities | at 2016-03-31 | $1.45bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2016-03-31 | $1.99bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2016-03-31 | $1.8m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2016-03-31 | $112.4m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2016-03-31 | $1.96bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2016-03-31 | 133,751,548 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 50,074 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, "expect", “expects”, “should”, “could”, “may”, “will continue to”, "believe", “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and

unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of

activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2015 (the “2015 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2015 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Critical Accounting Policies” section in our 2015 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Revenue recognition and trade receivables
- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to the condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Lithium. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals - insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. The FMC Health and Nutrition segment focuses on nutritional ingredients, health excipients, and functional health ingredients. Nutritional ingredients are used to enhance texture, color, structure and physical stability. Health excipients are used for binding, encapsulation and disintegrant applications. Functional health ingredients are used as active ingredients in nutraceutical and pharmaceutical markets. Our FMC Lithium segment manufactures lithium for use in a wide range of lithium products, which are used primarily in energy storage, specialty polymers and chemical synthesis application.

### First Quarter 2016 Highlights

The following are the more significant developments in our businesses during the three months ended March 31, 2016:

- Revenue of $798.8 million for the three months ended March 31, 2016 increased $139 million or 21 percent versus the same period last year. The increase in revenue was attributable to FMC Agricultural Solutions and the acquisition of Cheminova, completed in April 2015. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in North America decreased 24 percent period the over period while sales in Asia improved by 16 percent, and sales in Latin America increased 21 percent, sales in Europe, Middle East and Africa increased by 160 percent primarily due to the acquisition of Cheminova.
- Our gross margin, excluding acquisition-related charges, increased by approximately $31 million or approximately twelve percent to $281 million versus the prior year's first quarter. Gross margin percent of 35 percent declined from 38 percent. The increase in gross margin was due to higher sales in the first quarter of 2016 due to the Cheminova acquisition. The gross margin percentage decline was driven primarily by unfavorable currency movements.
- Selling, general and administrative expenses, excluding acquisition-related charges and non-operating pension and postretirement charges increased by approximately $17 million or 17 percent to $118 million. The increase was driven primarily by the acquisition of Cheminova which is being integrated into our FMC Agricultural Solutions segment.
- Research and Development expenses of $36 million increased $9 million or 35 percent.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $78.4 million was essentially flat compared to the prior year amount of $77.7 million. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".

### Other Highlights

In our Agricultural Solutions business, we continue to see the benefits of the Cheminova acquisition, which brought greater scale and regional balance to our business, improved our market access and expanded our product portfolio and technology pipeline.

In Health and Nutrition, global demand for our naturally-derived ingredient product lines continues to grow and we remain focused on protecting the business’s high margins through the implementation of Manufacturing Excellence programs, process technology improvements and product differentiation.

In Lithium, we are seeing the benefits of our strategy to grow our business in the technology-driven specialty end markets, where demand continues to accelerate and pricing trends across our portfolio remain favorable.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2016 Revenue | Three Months Ended March 31 | 2015 |
| --- | ---: | ---: |
| FMC Agricultural Solutions | $546.1 | $392.4 |
| FMC Health and Nutrition | 192.4 | 211.0 |
| FMC Lithium | 60.3 | 56.0 |
| **Total** | **$798.8** | **$659.4** |
| **Income (loss) from continuing operations before income taxes** |  |  |
| FMC Agricultural Solutions | $82.0 | $81.8 |
| FMC Health and Nutrition | 47.3 | 51.0 |
| FMC Lithium | 14.9 | 5.5 |
| **Segment operating profit** | **$144.2** | **$138.3** |
| Corporate and other | (16.9) | (15.3) |
| **Operating profit before the items listed below** | **$127.3** | **$123.0** |
| Interest expense, net | (20.8) | (14.0) |
| Corporate special (charges) income: |  |  |
| Restructuring and other (charges) income (1) | (12.4) | (22.3) |
| Non-operating pension and postretirement charges (2) | (1.0) | (6.2) |
| Acquisition-related charges (3) | (7.4) | (190.7) |
| (Provision) benefit for income taxes | (30.9) | 49.1 |
| Discontinued operations, net of income taxes | (6.1) | 15.6 |
| Net income attributable to noncontrolling interests | (0.4) | (1.3) |
| **Net income (loss) attributable to FMC stockholders** | **$48.3** | **$(46.8)** |

(1) See Note 8 for details of restructuring and other (charges) income. Below provides the detail the (charges) income by segment:

*(in Millions)*

|  | Three Months Ended March 31 2016 | 2015 |
| --- | ---: | ---: |
| FMC Agricultural Solutions | $(6.6) | $(18.3) |
| FMC Health and Nutrition | (0.2) | (2.2) |
| FMC Lithium | (0.6) | (0.3) |
| Corporate | (5.0) | (1.5) |
| **Restructuring and other (charges) income** | $(12.4) | $(22.3) |

(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss).

(3) Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, transaction costs, costs for transitional employees, other acquired employee related costs, integration related legal and professional third-party fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following:

*(in Millions)*

| Acquisition-related charges - Cheminova | Three Months Ended March 31 2016 | 2015 |
| --- | ---: | ---: |
| Legal and professional fees (1) | $7.4 | $10.6 |
| (Gain)/loss on hedging purchase price (1) | — | 180.1 |
| **Acquisition-related charges** | **$7.4** | **$190.7** |

(1) On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expenses.” For more information on the loss on purchase price hedge see Note 3 to the condensed consolidated financial statements included within this Form 10-Q.

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income (loss) attributable to FMC stockholders.” We believe that this measure provides useful information about our operating results to investors. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, and certain Non-GAAP tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2016 | Three Months Ended March 31 | 2015 |
| --- | ---: | ---: |
| **Net income (loss) attributable to FMC stockholders (GAAP)** | $48.3 | $(46.8) |
| Corporate special charges (income), pre-tax | 20.8 | 219.2 |
| Income tax expense (benefit) on Corporate special charges (income) | (6.4) | (80.5) |
| Corporate special charges (income), net of income taxes | $14.4 | $138.7 |
| Discontinued operations attributable to FMC Stockholders, net of income taxes | 6.1 | (15.6) |
| Non-GAAP tax adjustments (1) | 9.6 | 1.4 |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | **$78.4** | **$77.7** |

(1) We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the projected annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but are not limited to: income tax expenses or benefits that are not related to ongoing business operations in the current year; unusual or infrequently occurring items; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets; and changes in tax law. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance.

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition-related charges, and other income and expense items.

Information about how each of these items relates to our businesses at the segment level and results by segment is discussed in Note 18 of the condensed consolidated financial statements included within this Form 10-Q and in Note 19 of our consolidated financial statements in our 2015 Form 10-K.

### FMC Agricultural Solutions

*(in Millions)*

| 2016 | Three Months Ended March 31 | 2015 |
| --- | ---: | ---: |
| Revenue | $546.1 | $392.4 |
| Operating Profit | 82.0 | 81.8 |

### Three months ended March 31, 2016 vs. 2015

Revenue of $546.1 million increased approximately 39 percent versus the prior year quarter due to the revenue from the Cheminova acquisition.

FMC Agricultural Solutions' operating profit of $82.0 million is flat compared to the year-ago quarter.

Refer to the ***FMC Agricultural Solutions Proforma Financial Results with Cheminova*** section below for further discussion.

### FMC Agricultural Solutions Pro forma Financial Results with Cheminova

We believe that reviewing our operating results for these interim periods by combining actual and pro forma results for the FMC Agricultural Solutions segment for 2016 and 2015 is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of this segment. Our pro forma segment information will include adjustments as if the Cheminova transaction had occurred on January 1, 2015. Our pro forma data will also be adjusted for the effects of acquisition accounting but will not include adjustments for cost related to integration activities, cost savings or synergies that might be achieved by the combined businesses. Pro forma amounts to be presented will not necessarily be indicative of what our results would have been had we operated Cheminova since January 1, 2015, nor our future results.

*(in Millions)*

| FMC Agricultural Solutions Pro Forma Financial Results Revenue | Three Months Ended March 31 2016 | 2015 |
| --- | ---: | ---: |
| Revenue, FMC Agricultural Solutions, as reported (1) | $546.1 | $392.4 |
| Revenue, Cheminova, pro forma (2) | — | 304.1 |
| **Pro Forma Combined, Revenue (3)** | **$546.1** | **$696.5** |
| **Operating Profit** |  |  |
| Operating Profit, FMC Agricultural Solutions, as reported (1) | $82.0 | $81.8 |
| Operating Profit, Cheminova, pro forma (2) | — | 24.0 |
| **Pro Forma Combined, Operating Profit (3)** | **$82.0** | **$105.8** |

(1) As reported amounts are the results of operations of FMC Agricultural Solutions, including the results of the Cheminova acquisition from April 21, 2015 onward.

(2) Cheminova pro forma amounts include the historical results of Cheminova, prior to April 21, 2015. These amounts also include adjustments as if the Cheminova transaction had occurred on January 1, 2015, including the effects of acquisition accounting. The pro forma amounts do not include adjustments for expenses related to integration activities, cost savings or synergies that may have been or may be achieved by the combined segment.

(3) The pro forma combined amounts are not necessarily indicative of what the results would have been had we acquired Cheminova on January 1, 2015 or indicative of future results.

*FMC Agricultural Solutions Pro Forma Combined Revenue by Region (1)*

*(in Millions)*

|  | Three Months Ended March 31 2016 | 2015 |
| --- | ---: | ---: |
| Europe, Middle East and Africa (EMEA) (2) | $205.3 | $229.8 |
| North America (3) | 150.0 | 229.4 |
| Latin America (4) | 101.0 | 133.8 |
| Asia (5) | 89.8 | 103.5 |
| **Total** | **$546.1** | **$696.5** |

(1) The pro forma combined revenue by region amounts are not necessarily indicative of what the results would have been had we acquired Cheminova on January 1, 2015 or indicative of future results.

(2) Decline driven by cold weather in Western Europe partially offset by Central/Eastern Europe demand growth as well as transition to direct market access across the region and synergies from the Cheminova acquisition.

(3) Decline driven by elevated channel inventory levels partially offset by new product introductions.

(4) Decline driven by Brazil where elevated inventory levels remain high. In Latin America outside of Brazil, export demand was strong and trade conditions in Argentina improved revenue.

(5) Decline driven by poor weather in India and South East Asia partially offset by increasing pesticide demand in China as well as favorable weather conditions in Australia.

### Pro Forma Combined Results - Three months ended March 31, 2016 vs. 2015

Pro forma combined revenue of $546.1 million decreased by approximately 22 percent versus the prior year quarter. Lower volumes impacted revenue negatively by 19 percent while unfavorable currency impacted revenue by four percent. Lower volumes were primarily experienced in North America and Brazil, due to high channel inventories and planned product rationalizations. The actions we took to eliminate certain product sales reduced revenue by approximately $30 million compared to pro forma combined revenue in the first quarter of 2015. The product rationalization had a limited impact on segment earnings.

Pro forma combined operating profit of $82 million decreased approximately 23 percent compared to the year-ago period. Foreign currency contributed 14 percent to the decline in year over year pro forma combined operating profit while the lower volumes described above contributed 31 percent to the decline. Higher pricing partially offset the decline by 9 percent while lower costs, primarily selling, general and administrative combined with lower research and development costs improved profits year over year by 13 percent. These lower costs were the result of cost savings driven by synergies associated with the Cheminova acquisition.

### Outlook

For 2016, full-year segment revenue is still expected to be approximately $2.3 billion to $2.5 billion and full-year segment earnings are still expected to be in the range of $380 million to $420 million.

#### Certain Regulatory Issues

A detailed discussion related to regulatory issues impacting FMC Agricultural Solutions can be found in Part II, Item 7 of our 2015 Form 10-K. There have been no material changes related to regulatory issues impacting FMC Agricultural Solutions from the information reported in our 2015 10-K.

### FMC Health and Nutrition

*(in Millions)*

| 2016 | Three Months Ended March 31 | 2015 |
| --- | ---: | ---: |
| Revenue | $192.4 | $211.0 |
| Operating Profit | 47.3 | 51.0 |

### Three months ended March 31, 2016 vs. 2015

Revenue of $192.4 million decreased approximately nine percent versus the prior-year quarter. Revenue in the first quarter of 2015 included certain Omega-3 sales which were not repeated in 2016. These sales related principally to pharmaceutical API products and accounted for nine percent of the revenue decline in 2016. Excluding this sales volume, price, volume and impacts of foreign exchange were roughly flat year on year.

Segment operating profit of $47.3 million decreased approximately seven percent versus the year ago quarter. The lower sales volume associated with the Omega-3 sales noted above impacted segment operating profit by 13 percent. Lower operating costs positively impacted results by seven percent.

### Outlook

Segment revenue for the full year of 2016 is still anticipated to be approximately $775 million to $825 million, while full-year segment earnings are expected to be between $198 million and $208 million.

### FMC Lithium

*(in Millions)*

| 2016 | Three Months Ended March 31 | 2015 |
| --- | ---: | ---: |
| Revenue | $60.3 | $56.0 |
| Operating Profit | 14.9 | 5.5 |

### Three months ended March 31, 2016 vs. 2015

Revenue of $60.3 million increased by approximately eight percent versus the prior-year quarter. Higher volumes, primarily in specialty products contributed 5 percent to the revenue increase while higher pricing, net of minor currency headwinds, impacted revenue favorably by 3 percent. Demand trends across specialty end markets remain strong. Hydroxide demand for energy storage and EV applications continues to grow at double digits.

Segment operating profit of $14.9 million increased $9.4 million versus the year ago quarter. The favorable volume and pricing noted above each impacted results by $2 million. Operating costs were lower by approximately $5 million, driven by manufacturing efficiencies from ongoing process improvements as well as from savings associated with the natural gas pipeline installed in 2015.

### Outlook

Due to the improved forecast for this business, segment earnings are now expected to be between $43 and $53 million for the full year of 2016, an increase of 108 percent over 2015 at the mid-point of the range and $10 million higher than the previous range.

### Other Results of Operations

#### Corporate and other

Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on the condensed consolidated statements of income (loss).

### Three months ended March 31, 2016 vs. 2015

Corporate and other expenses of $16.9 million in the first quarter of 2016 increased by $1.6 million from $15.3 million in the same period in 2015.

#### Interest expense, net

### Three months ended March 31, 2016 vs. 2015

Interest expense, net for the first quarter of 2016 was $20.8 million as compared to the first quarter of 2015 of $14.0 million. The increase was primarily due to our borrowings that took place in the second quarter of 2015 under the previously announced senior unsecured Term Loan Facility. The proceeds of the borrowing were used to finance the acquisition of Cheminova as well as to pay costs, fees and expenses incurred in connection with the acquisition and the Term Loan Facility.

#### Corporate special charges (income)

### Three months ended March 31, 2016 vs. 2015

#### Restructuring and other charges (income)

*(in Millions)*

|  | Three Months Ended March 31 2016 | 2015 |
| --- | ---: | ---: |
| Restructuring charges and asset disposals | $3.2 | $5.4 |
| Other charges (income), net | 9.2 | 16.9 |
| Total restructuring and other charges | $12.4 | $22.3 |

Restructuring and asset disposal charges in 2016 of $3.2 million were primarily associated with the Cheminova restructuring that was implemented as part of the integration of Cheminova into our existing FMC Agricultural Solutions segment for the quarter. Other charges (income) net in 2016 of $9.2 million were primarily related to $6.6 million of environmental related charges as well as $4.2 million of charges associated with currency devaluation within Argentina as a result of deliberate actions by the government of that country. See Note 8 within the condensed consolidated financial statements included in this Form 10-Q for more information.

Restructuring and asset disposal charges in 2015 of $5.4 million were primarily associated with Health and Nutrition. Other charges (income) net in 2015 of $16.9 million were primarily related to corporate environmental charges of $1.9 million and $15 million of charges associated with an exclusive license, development and supply agreement for a novel crop protection product for agricultural use in the United States. The rights and technology obtained is referred to as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination.

The liabilities associated with the restructuring charges listed above are also included within Note 8 to the condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.

#### Non-operating pension and postretirement charges

The charge for the three months ended March 31, 2016 was $1.0 million compared to $6.2 million for the three months ended March 31, 2015. See Note 14 to the condensed consolidated financial statements included in this Form 10-Q for more information. These expenses are included as a component of the line item "Selling, general and administrative expenses" on the condensed consolidated statements of income (loss).

#### Acquisition-related charges

A detailed description of the acquisition-related charges is included in Note 18 to the condensed consolidated financial statements included within this Form 10-Q.

#### Provision for income taxes

A significant amount of our earnings is generated by our foreign subsidiaries (e.g. Denmark, Ireland, and Hong Kong), which tax earnings at lower rates than the United States federal statutory rate. Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; expiration of statute of limitations or settlement of tax audits; changes in valuation allowance and changes in tax law; and the potential decision to repatriate certain future foreign earnings on which United States taxes have not been previously accrued.

### Three months ended March 31, 2016 vs. 2015

Provision for income taxes was $30.9 million resulting in an effective tax rate of 36.1 percent compared to a benefit of $49.1 million resulting in an effective tax rate of 44.6 percent for the three months ended March 31, 2016 and 2015, respectively. Additional detail explaining the change in the GAAP effective tax rate is presented in Note 15 to the condensed consolidated financial statements included within this Form 10-Q. Below is a table that adjusts our income and taxes for the effect of corporate special charges and certain tax adjustments. We believe showing this reconciliation of our GAAP to Non-GAAP effective tax rate provides investors with useful supplemental information about our tax rate on the core underlying business.

*(in Millions)*

|  | Three Months Ended March 31 2016 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | 2015 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP - Continuing operations** | $85.7 | $30.9 | 36.1% | $(110.2) | $(49.1) | 44.6% |
| Corporate special charges | 20.8 | 6.4 |  | 219.2 | 80.5 |  |
| Tax adjustments (1) |  | (9.6) |  |  | (1.4) |  |
| **Non-GAAP - Continuing operations** | $106.5 | $27.7 | **26.0%** | $109.0 | $30.0 | **27.5%** |

(1) Refer to footnote 1 on page 34 of this Form 10-Q for an explanation of Tax adjustments.

The primary drivers for the fluctuations in the effective tax rate from 2015 to 2016 are provided in the table above. Excluding the items in the table above, the change in the effective tax rates from 2015 to 2016 was primarily due to a shift in earnings mix as it relates to domestic versus foreign income. Foreign profits are generally taxed at lower rates compared to domestic income.

#### Discontinued operations, net of income taxes

Our discontinued operations represent our discontinued FMC Alkali Chemicals up through the date of sale of that business on April 1, 2015 as well as adjustments to retained liabilities from other previously discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

### Three months ended March 31, 2016 vs. 2015

Discontinued operations, net of income taxes represented a loss of $6.1 million for the three months ended March 31, 2016, compared to a gain of $15.6 million for the three months ended March 31, 2015. The change was driven by the discontinued operations of our FMC Alkali Chemicals division which were included in the three months ended March 31, 2015.

#### Net income (loss) attributable to FMC stockholders

### Three months ended March 31, 2016 vs. 2015

Net income attributable to FMC stockholders increased to income of $48.3 million from a loss of $46.8 million. The increase was primarily a result of significantly lower acquisition costs associated with the Cheminova acquisition.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at March 31, 2016 and December 31, 2015, were $64.3 million and $78.6 million, respectively. Of the cash and cash equivalents balance at March 31, 2016, $60.8 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings.

At March 31, 2016, we had total debt of $2,100.4 million as compared to $2,148.9 million at December 31, 2015. Total debt included $1,986.2 million and $2,036.3 million of long-term debt (excluding current portions of $1.8 million and $1.5 million) at March 31, 2016 and December 31, 2015, respectively. As of March 31, 2016, we were in compliance with all of our debt covenants. During 2016, the maximum leverage ratio will step down in accordance with the provisions of the Credit Facility and the Term Loan Facility. Additionally, we will take a variety of steps, if necessary, to ensure compliance with the maximum leverage ratio at the applicable measurement dates. See Note 9 in the condensed consolidated financial statements included in this Form 10-Q for further details.

Short-term debt, which consists of borrowings under our commercial paper program as well as short-term foreign borrowings, increased slightly from $112.6 million at December 31, 2015 to $114.2 million at March 31, 2016.

Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. We have used proceeds from the commercial paper program for general corporate purposes. At March 31, 2016, the average effective interest rate on these borrowings was 0.65%.

### Statement of Cash Flows

*Cash provided (required) by operating activities of continuing operations was $107.2 million and $(304.9) million for the three months ended March 31, 2016 and 2015, respectively.*

The table below presents the components of net cash provided (required) by operating activities of continuing operations.

*(in Millions)*

| 2016 | Three Months Ended March 31 | 2015 |
| --- | ---: | ---: |
| Income (loss) from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes | $106.5 | $(96.1) |
| Corporate special charges and depreciation and amortization (1) | 54.4 | 241.9 |
| **Operating income before depreciation and amortization (Non-GAAP)** | **$160.9** | **$145.8** |
| Change in trade receivables (2) | 83.3 | 52.5 |
| Change in inventories (3) | (53.8) | (50.0) |
| Change in accounts payable (4) | 123.2 | (35.6) |
| Change in accrued rebates (5) | 79.4 | 87.6 |
| Change in advance payments from customers (6) | (199.2) | (165.9) |
| Change in all other operating assets and liabilities (7) | (34.3) | 9.3 |
| **Cash basis operating income (Non-GAAP)** | **$159.5** | **$43.7** |
| Restructuring and other spending (8) | (8.1) | (3.0) |
| Environmental spending, continuing, net recoveries (9) | (2.7) | (3.0) |
| Pension and other postretirement benefit contributions (10) | (2.1) | (27.4) |
| Net Interest payments (11) | (23.7) | (18.0) |
| Tax payments | (8.0) | (11.1) |
| Excess tax benefits from share-based compensation | (0.3) | (1.7) |
| Payments associated with the Cheminova purchase price hedges (12) | — | (273.8) |
| Acquisition related charge | (7.4) | (10.6) |
| **Cash provided (required) by operating activities of continuing operations** | **$107.2** | **$(304.9)** |

(1) Represents the sum of corporate special charges and depreciation and amortization.

(2) The change in cash flows related to trade receivables in 2016 was primarily driven by timing of collections. Additionally, the increased focus last year on sales terms in Agricultural Solutions as well as ongoing collection measures also in Agricultural Solutions contributed to the higher change in trade receivables period over period.

(3) Inventory changes are relatively flat year over year and levels are adjusted accordingly to take into consideration the change in market conditions primarily in Agricultural Solutions.

(4) The change in accounts payable in 2016 is primarily due to timing of payments

(5) These rebates are associated with our FMC Agricultural Solutions segment in North America and Brazil and generally settle in the fourth quarter of each year. The changes year over year are primarily associated with the mix in sales eligible for rebates and incentives in 2016 compared to 2015 and timing of rebate payments.

(6) The advance payments from customers represent advances from our FMC Agricultural Solutions segment customers.

(7) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities, including guarantees issued to vendors under our vendor finance program.

(8) See Note 8 in our consolidated financial statements included in this Form 10-Q for further details.

(9) Included in the period resented are environmental charges for environmental remediation at our operating sites of $6.6 million and $1.9 million, respectively. The amounts in 2016 will be spent in future years. The amounts represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(10) There were no voluntary contributions to our U.S. defined benefit plans in 2016 and $25 million included in 2015.

(11) The increase in interest payments form 2015 to 2016 was due to higher debt levels as a result of borrowings needed for the Cheminova acquisition.

(12) Represents payments for legal and professional fees associated with the Cheminova acquisition. See also Note 3 to the financial statements including in the Form 10-Q for more information.

*Cash provided (required) by operating activities of discontinued operations was $(6.9) million and $7.7 million for the three months ended March 31, 2016 and 2015, respectively.*

Cash required by operating activities of discontinued operation is directly related to environmental, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities. Amounts in 2015 included operating activities of FMC Alkali Chemicals business.

*Cash required by investing activities of continuing operations was $(44.5) million and $(54.2) million for the three months ended March 31, 2016 and 2015, respectively.*

The reduction in cash required in spending during the three months ended March 31, 2016, as compared to the same period in 2015 was due to higher capital expenditures offset by lower spending in other investing activities compared to 2015.

*Cash required by investing activities of discontinued operations was $0.0 million and $(15.6) million for the three months ended March 31, 2016 and 2015, respectively.*

Cash required by investing activities of discontinued operations in 2015 is directly associated with capital expenditures associated with the Alkali business.

*Cash provided (required) by financing activities was $(71.0) million and $364.8 million for the three months ended March 31, 2016 and 2015, respectively.*

The change period over period in financing activities is primarily due to the the repayment of our long term debt of $50.3 million under our previously announced senior unsecured Term Loan facility. The increased borrowings in 2015 was primarily to fund the settlement of the purchase price hedges for the Cheminova A/S acquisition.

### Other potential liquidity needs

Our cash needs outside of the Cheminova acquisition and related integration expenses for 2016 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At March 31, 2016, our remaining borrowing capacity under our credit facility was $1,410.7 million (which includes borrowings under our commercial paper program).

Projected 2016 capital expenditures as well as expenditures related to contract manufacturers are expected to be lower than 2015 levels. This includes expected spending for Cheminova subsequent to the acquisition.

Projected 2016 spending includes approximately $50 million to $55 million of net environmental remediation spending. This spending does not include expected spending on capital projects relating to environmental control facilities or expected spending for environmental compliance costs, which we will include as a component of costs of sales and services to the condensed consolidated statements of income (loss) since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we expect to make approximately $35 million in voluntary cash contributions to our U.S defined pension plan during 2016. These contributions are in excess of the minimum requirements. We did not make any of these contributions in the first quarter of 2016. We do not believe that these projected contributions will have a significant negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.

For the three months ended March 31, 2016 and 2015, we paid $22.1 million and $20.1 million, respectively, in dividends declared. On April 21, 2016, we paid dividends totaling $22.2 million to our shareholders of record as of March 31, 2016. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of March 31, 2016.

During the three months ended March 31, 2016, no shares were repurchased under the publicly announced repurchase program. At March 31, 2016, $250.0 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

### Commitments and Contingencies

See Note 17 to the condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2015 can be found in a table included within Part II, Item 7 of our 2015 Form 10-K. There have been no significant changes to our contractual commitments during the three months ended March 31, 2016.

### Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2015 Form 10-K.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair-Value Measurements

See Note 16 to the condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At March 31, 2016, our financial instrument position was a net liability of $36.0 million compared to a net liability of $13.4 million at December 31, 2015. The change in the net financial instrument position was primarily due to change in exchange rates.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

### Commodity Price Risk

Energy costs are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at March 31, 2016 and December 31, 2015, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged energy exposure vs. Energy market pricing 10% Increase | 10% Decrease |
| --- | ---: | ---: | ---: |
| **Net asset/(liability) position at March 31, 2016** | $(2.4) | $(1.7) | $(3.0) |
| **Net asset/(liability) position at December 31, 2015** | $(7.3) | $(5.3) | $(9.4) |

Our FMC Agricultural Solutions segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of March 31, 2016 and December 31, 2015 our net financial instrument position was immaterial.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan, the U.S. dollar versus the Brazilian real and the U.S. dollar versus the Argentine peso. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at March 31, 2016 and December 31, 2015, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged Currency vs. Functional Currency 10% Strengthening | 10% Weakening |
| --- | ---: | ---: | ---: |
| **Net asset/(liability) position at March 31, 2016** | $(33.6) | $(6.4) | $(72.9) |
| **Net asset/(liability) position at December 31, 2015 (1)** | $(85.2) | $91.3 | $(261.0) |

(1) Includes the unrealized loss on hedging the purchase price of Cheminova as of December 31, 2014. See "Cheminova Acquisition Hedge Costs" in Note 3 to the condensed consolidated financial statements included in this Form 10-Q.

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of March 31, 2016 and December 31, 2015, we had no interest rate swap agreements.

Our debt portfolio, at March 31, 2016, is composed of 57 percent fixed-rate debt and 43 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Term Loan Facility, Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at March 31, 2016, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $2.3 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $1.2 million for the three months of March 31, 2016.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,372 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2016, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended March 31, 2016, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of March 31, 2016, the related condensed consolidated statements of income (loss), comprehensive income (loss), and cash flows for the three-month periods ended March 31, 2016 and 2015. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2015, and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity for the year then ended (not presented herein); and in our report dated February 26, 2016, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2015, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

**/s/** KPMG LLP

Philadelphia, Pennsylvania

May 3, 2016

## Risk factors

As filed, 500 characters.

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A "Risk Factors" of our 2015 Form 10-K. The risks described in our Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.

Filed May 3, 2016.
Source: SEC EDGAR, the filing index for accession 0000037785-16-000087. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
